This report is concerned with the development and application of a new technique for measurement of hepatic blood flow and portal circulation time.
The methods by which a patient with clinical liver disease can be studied have been generally limited to tests of hepatic function and tissue biopsy. Recently, however, transcutaneous splenic punctures have been employed not only for visualization of the portal circulation by radiographic techniques (splenoportography) (1-3) but also as a means of determining the level of portal venous pressure (4) (5) (6) (7) . Anatomical studies have shown that the splenic pulp communicates directly with the portal venous system (8) . Similarly, radiopaque material injected into the splenic pulp is rapidly transported through the portal circulation within seconds following its instillation. Because of this direct communication, intrasplenic pulp pressure is a direct reflection of portal venous pressure. The latter has been confirmed by animal studies (4) , at surgery in humans, by direct needling of the portal triads during liver biopsy and by hepatic vein wedge pressure catheterization studies (9) .
The interrelationship of the splenic and portal circulations suggested that portal circulation time might be measured by injection of a tracer material into the spleen and observation of its course through the portal system. In addition, measure-ment of blood flow through the hepatic vascular bed might be calculated by application of the Stewart-Hamilton indicator dilution method (10) . This method is based on the hydraulic principle that the flow within a moving stream may be determined by its ability to dilute a known amount of indicator measured with respect to time.
The requirements for application of the indicator dilution method to the portal circulatory system in man would appear to be: 1. It must be possible to inject a known amount of indicator substance which then remains entirely within the vascular system.
2. Once injected, all of the indicator must traverse the liver, i.e., there must be no shunt of injected indicator prior to the intrahepatic circulation.
3. The indicator must mix with the dual blood supply of the liver prior to the site of final sampling. 4 . It must be possible to carry out uniform continuous or rapid intermittent sampling of the flow of blood as it exits from the area of complete mixing through to the first recirculation.
It will be the purpose of this report to demonstrate that under certain conditions these abovementioned requirements may be met and, therefore, blood flow and circulation times through the liver may be measured by a dilution technique.
MATERIAL AND METHODS
Studies were carried out in 43 subjects: 14 were normal, 16 distal end of the tubing was begun prior to actual injection of the radioactive indicator and maintained at a steady rate by manual traction during study. Because of the inherent resistance within the catheter, it was relatively easy to maintain a steady rate of flow. The rate of flow in ml. per second was timed carefully by another observer (average, 0.6 ml. per second). The change in concentration of radioactivity as a function of time during the primary circulation was recorded on a semilogarithmic graphic ammeter 6 which received the count rate computer output (11) (Figure 1 ). The final 10 minute equilibrium of circulating isotope was measured in the direct recording system and then a 1 ml. blood sample counted directly in a well counter.
2. External suprahepatic surface counting. A 1 inch scintillation probe counter with a 2.5 inch collimation was placed over the right anterior costal margin at about the midclavicular line and angled slightly laterally to view a portion of the right lobe of the liver. This probe was similarly wired to a decade scaler and count rate computer 5 with counts registered directly on a semilogarithmic graphic recorder.6 Background counts per minute were recorded over the liver. Following splenic injection, a curve of dilution was inscribed ( Figure 1 ). The probe was left exactly in the same place over the liver; final dilution of isotope was measured at 10 minutes in the same vascular pool sampled by the probe during dilution. Finally radioactivity was measured over the subapical re-gion of the right chest 7; this value was subtracted from the final dilution to correct for isotope equilibrated in nonhepatic vascular tissues (skin, bone, muscle and so forth) but "seen" by the counter after body equilibration.
Fractional two second sampling was performed from the brachial artery at the same time as hepatic venous sampling. Immediately after the flow, hepatic vein and systemic arterial samples were drawn for gasometric analysis. Blood was drawn at 10 minutes as a measure of final indicator dilution to calculate blood volume obtained following intrasplenic injection. A blood volume was also measured following a separate intravenous injection of iodinated serum albumin before the hepatic flow study was carried out. Usually the indicator was injected via the catheter in the hepatic vein and fraction collection carried out from the brachial artery in order to measure hepatic-systemic arterial circulation time and cardiac output, as well as blood volume. Radioactive blood samples were analyzed in a well counter and the values recorded as counts per minute (cpm) per ml.
Liver blood flow was also estimated by the bromsulfalein method (12) in six patients.
In four patients undergoing splenectomy, intrasplenic sequestration of indicator was tested by direct examination of the spleen following its removal. Immediately prior to surgical removal of the spleen, 1 ml. containing 50 /Ac. of radioactive iodinated serum albumin was injected directly into the splenic pulp. The splenic vein was clamped within 5 to 45 seconds after this injection. The excised spleen was then assayed for radioactivity and compared to a known standard containing an amount of radioactivity equivalent to that injected into the spleen. injection was performed as indicated by the fact that splenic pulp blood could be withdrawn both before and after injection, there was a rise in suprasplenic radioactivity followed by an immediate fall to levels of between 5 and 10 per cent of the total dose. This was corroborated by the findings in four patients in whom the splenic vein was clamped following injection into the 7 The counter probe "sees" isotopes in other nonhepatic tissue as well as in liver. Ideal control for nonhepatic background would best be obtained from the same area over the left costal margin. This was not practical because of possible radiation from the site of splenic injection. It was found empirically, however, that the right anterior subapical region of the chest had a radioactivity similar to the left costal margin. vertheless, a satisfactory hepatic dilution the accuracy of the determination of two blood could still be written from that amount of volumes and, secondly, on the nature of the left :ed material which did leave the splenic pulp upper quadrant, presumably nonvascular extras the curve was too flat in relation to the splenic radioactivity. The error for a single in activity of the final dilution sample (Fig-blood volume is + 5.4 per cent due to blood volume determination alone. Similarly, the error Calculation of total effective splenic intra-in the graphic recording of cpm per ml. is estilar injection. Because of the frequent prob-mated to be of the order of + 5 per cent. There-)f partial extrasplenic loss, or subcapsular fore, the total probable error due to radioactive stration of indicator, it was necessary to de-mensuration is about ± 8 per cent. ne "total effective intravascular injection." Delayed entry of isotope (trailing in the curve) Described elsewhere (11, 13) , equilibration resulted only from a slow, uneven injection into on of isotope 10 minutes following intra-the spleen. Any level of radioactivity which could ic injection was determined graphically in be counted over the left upper quadrant after inper ml. for each direct recording system and jection appeared stable without decline for hours appropriate background correction, multi- (Figures 2 and 3) . The method of calculation of by a whole blood volume determined at dose from previously determined blood volume (11, er time. This figure gave the effective intra-13) obviated not only errors of total intrasplenic lar injectate as "seen" by each counting sys-injection but also errors in manipulation of the 11, 13). The measurement of whole blood syringe and needle at the site of splenic puncture. ie was determined by standard techniques 3. Lack of hepatic removal of indicator subein an accurate dose of indicator could be stance. a. With technically successful intrared intravenously and its dilution measured splenic injection of indicator, blood volume calcuend of 10 minutes.
lated from total intrasplenic injectate equalled e accuracy of this method depends first upon that obtained using intravenous injection. D. Uniform sampling of hepatic venous blood.
FIG. 4. ACTUAL CURVES OBTAINED DURING SIMULTANEOUS MEASUREMENTS OF HEPATIC FLOW BY SUPRAHEPATIC, HEPATIC VENOUS AND BROMSULFALEIN METHODS
Uniformity in sampling techniques was demonstrated first by the reproducibility of consecutive determinations of hepatic blood flow in five patients (Table II) and second, by the comparison of flows determined by three separate simultaneous methods (Table IV and Figure 4 ).
Calculations
A typical calculation of hepatic flow following hepatic venous sampling is shown in Figure 5 . In brief, injectate is derived as the product of Figure 5 is taken from MacIntyre, Pritchard, Eckstein and Friedell (11) . When the suprahepatic counting method is used the calculation is essentially similar except that the isotope dilution recorded over the right subapical region after 10 minutes is subtracted from the final dilution recorded over the liver at 10 minutes. In this manner, nonhepatic vascular isotope counts are eliminated in estimation of final dilution of injectate in the hepatic vascular pool (Figure 4 ). Figure 4 .
In Figure 6 is shown a comparison of hepatic blood flows in normal patients and in patients with acute hepatitis, cirrhosis and cirrhosis with prehepatic shunts. There was no apparent change in blood flow except for a decrease in those with cirrhosis and varices.
Observations of regional circulation times are presented in Table V (17) and Tornvall and Odeblad (18) . Tagged material was injected into the aorta and sampling from the hepatic vein carried out. These measurements, however, revealed only hepatic circulation times and not hepatic blood flow and were complicated by the dual supply of blood to the liver. The use of colloidal chromic phosphate and radiogold has also been described and is dependent upon the complete extraction of material in one circulation, presumably by the hepatic reticuloendothelial cells (19, 20) . Finally, Egeli has described a portal circulation time from spleen to tongue following intrasplenic injection of decholin and calcium (21) .
Evidence that the indicator dilution principle might be adapted to the splenoportal circulation was initially deduced from studies with Evans T-1824 dye. Following its intrasplenic injection, spectrophotometric analysis of multiple hepatic vein samples indicated that a characteristic dilution curve could be obtained. However, this dye could not be recovered completely, presumably due to loss from partial extrasplenic injection and into hepatic tissues [incomplete albumin binding due to high concentration in the portal circulation (22) ]. Accordingly, radioactive iodinated serum albumin was employed and an attempt made to satisfy the four criteria for application of the indicator dilution principle.
It was found that radioactive iodinated serum albumin left the spleen rapidly and passed through the liver without significant removal. In cirrhotic patients with prehepatic shunts, part of the injectate probably never entered the liver, and flows so recorded were undoubtedly falsely high or represented total splanchnic flow if mixing had occurred in the venous system. This may explain the statistically insignificant dif-ference in flows between normals and cirrhotics. Recognition of this possibility depended on clinical evidence of varices and premature arrival of isotope at the systemic artery whenever this occurred.
Good It must be emphasized that injectate "seen" by the counter is calculated from the product of a predetermined blood volume (11) and the radioactivity in cpm per minute per ml. in the vascular pool seen by the counter at equilibration. This means that the splenic injectate does not have to be accurately measured and that extrasplenic loss or intrasplenic sequestration will not necessarily vitiate a given flow measurement. When too much of the dose is injected outside the spleen, however, a flat curve may result with an inadequate rise in final dilution over the background count. With slow uneven injections trailing of isotope could also disturb the pattern and reliability of the curve (Figure 3) . Finally, unsteady sampling could distort the shape of the hepatic venous curve. When any of these technical errors occurred the curves were not considered suitable for analysis.
The comparison of suprahepatic and hepatic venous techniques appears to establish the reliability of an external counting method for determination of hepatic blood flow. In institutions where venous catherization is not available, the .external or suprahepatic method may be used in conjunction with intrasplenic pressure measurements for physiological studies of the portal circulation. Advantages of the method are that flow may be determined within the space of 1 minute, that the method is relatively innocuous, and that three to four measurements of flow may be determined on a given day with as little time as 10 minutes between each measurement. Because of the rapidity of the determination, this technique is suited for study of changing physiologic states such as alterations in posture, after exercise, food and the administration of drugs.
In severe cirrhosis, despite the probable shunting of some isotope past the liver, calculated blood flow was decreased. Changes were observed not only in blood flow but also in circulation times between given regions of the splenoportal hepatic circulation. For example in severe cirrhosis, intrahepatic transit time was diminished and in two individuals an hepatic vascular bypass could be detected. Such studies may be of value in the understanding of portal vein thrombosis, and the nature of the intrahepatic vascular abnormalities which occur in cirrhosis.
SUMMARY
A new technique for determining portal circulation times and hepatic blood flow is outlined. This method consists of measurement of the passage and dilution of radioactive iodinated serum albumin through the liver to the periphery following its intrasplenic injection. This pathway can be timed and followed by a scintillation counter placed externally over the liver and/or by scintillation well counting of blood collected continuously from the hepatic vein and the brachial artery.
Liver blood flow can be measured by application of the Stewart-Hamilton principle to either the hepatic vein or surface recorded radioactive dilution curve. The technique was shown to satisfy the basic requirements of an indicator dilution method except when applied to patients with prehepatic shunts. Methods for calibrating the total volume of effective intrasplenic injectate based on predetermined blood volume are presented.
The method was shown to be reproducible in 5 patients; similar hepatic flow values were obtained by both hepatic venous and surface scintillation counting techniques in 13 patients and compared well with the bromsulfalein method in 6 patients. Hepatic blood flow averaged 0.7 L. per minute per M.2 at rest in normal individuals. Normal spleen to liver arrival circulation time averaged 2.1 seconds; intrahepatic circulation time averaged 9.9 seconds.
